Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Luc Quaghebeur has worked on the following 19 EPO patent applications which have been published in the last five years:

EP11707172

IMIDAZO [1, 2 -A]PYRAZINE DERIVATIVES AND THEIR USE FOR THE PREVENTION OR TREATMENT OF NEUROLOGICAL, PSYCHIATRIC AND METABOLIC DISORDERS AND DISEASES

IPC classification:
A61K 31/4985, A61P 3/00, A61P 25/00, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
The patent has been granted
EP11804561

5,6-DIHYDRO-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)

IPC classification:
A61K 31/5025, A61P 25/00, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
GRANT OF PATENT INTENDED
EP12707276

6,7-DIHYDRO-PYRAZOLO[1,5-A]PYRAZIN-4-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)

IPC classification:
A61K 31/4985, A61P 25/28, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12707319

3,4-DIHYDRO-PYRROLO[1,2-a]PYRAZIN-1-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)

IPC classification:
A61K 31/4985, A61K 31/506, A61P 25/28, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12794731

6-DIFLUOROMETHYL-5,6-DIHYDRO-2H-[1,4]OXAZIN-3-AMINE DERIVATIVES

IPC classification:
A61K 31/5377, A61P 25/16, A61P 25/28, C07D 413/10, C07D 413/12
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12794730

5-(3-AMINOPHENYL)-5-ALKYL-5,6-DIHYDRO-2H-[1,4]OXAZIN-3-AMINE DERIVATIVES

IPC classification:
A61K 31/5377, A61P 25/00, C07D 265/30, C07D 413/12
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11729962

3-AMINO-5,6-DIHYDRO-1H-PYRAZIN-2-ONE DERIVATIVES USEFUL FOR THE TREATEMENT OF ALZHEIMER'S DISEASE AND OTHER FORMS OF DEMENTIA

IPC classification:
A61K 31/495, A61P 25/28, C07D 241/08, C07D 401/10, C07D 401/12, C07D 403/10
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14701007

NOVEL SUBSTITUTED PYRIDO-PIPERAZINONE DERIVATIVES AS GAMMA SECRETASE MODULATORS

IPC classification:
A61K 31/498, A61P 25/28, C07D 471/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
PATENT GRANTED
EP13814535

NOVEL TRICYCLIC 3,4-DIHYDRO-2H-PYRIDO[1,2-A]PYRAZINE-1,6-DIONE DERIVATIVES AS GAMMA SECRETASE MODULATORS

IPC classification:
A61K 31/4985, A61P 25/28, C07D 471/14
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
PATENT GRANTED
EP11784506

ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-A][1,4]- BENZODIAZEPINES AND 6H-PYRROLO[1,2-A][1,4]BENZODIAZEPINES SUBSTITUTED WITH PHENYL DERIVATIVES

IPC classification:
A61K 31/5517, A61P 31/10, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11748693

5-HT2B RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4468, A61P 11/00, C07D 211/58
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11757886

4,7-Dihydro-pyrazolo[1,5-a]pyrazin-6-ylamine derivatives useful as inhibitors of beta secretase (BACE)

IPC classification:
A61K 31/4985, A61P 25/28, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11781524

1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS

IPC classification:
A61K 9/00, A61K 9/06, A61K 9/10, A61K 9/20, A61K 31/5377, A61K 31/542, A61K 45/06, A61P 25/18, C07D 471/02, C07D 471/04
Applicant:
Janssen Pharmaceuticals Inc.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11723091

5-Amino-3,6-dihydro-1H-pyrazin-2-one derivatives useful as inhibitors of beta-secretase (BACE)

IPC classification:
A61K 31/496, A61P 25/16, A61P 25/28, C07D 401/10, C07D 401/12, C07D 403/10
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11723445

NOVEL ANTIFUNGAL 5,6-DIHYDRO-4-[(DIFLUORETHYL)PHENYL]-4H-PYRROLO[1,2-A][1,4]BENZODIAZEPAN AND 4-(DIFLUORETHYL)PHENYL-6H-PYRROLO[1,2-A][1,4]BENZODIAZEPIN DERIVATIVES.

IPC classification:
A61K 31/5517, A61P 31/10, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11802072

NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]- BENZODIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH BICYCLIC BENZENE DERIVATIVES

IPC classification:
A61K 31/5517, A61P 31/10, C07D 487/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11779667

1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS

IPC classification:
A61K 9/00, A61K 9/06, A61K 9/20, A61K 31/437, A61K 31/4545, A61K 31/496, A61K 31/498, A61K 31/5377, A61K 31/542, A61K 45/06, A61K 47/06, A61K 47/10, A61K 47/26, A61K 47/38, A61P 25/18, C07D 471/02, C07D 471/04
Applicant:
Janssen Pharmaceuticals Inc.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11781523

1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS

IPC classification:
A61K 9/00, A61K 9/06, A61K 9/20, A61K 31/437, A61K 31/542, A61K 45/06, A61P 25/18, C07D 471/02, C07D 471/04
Applicant:
Janssen Pharmaceuticals Inc.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11723974

5,6-DIHYDRO-2H-[1,4]OXAZIN-3-YL-AMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)

IPC classification:
A61K 31/535, A61K 31/5355, A61P 25/16, A61P 25/28, C07D 265/30, C07D 413/04
Applicant:
Janssen Pharmaceutica N.V.
Agent:
Luc Quaghebeur, Janssen Pharmaceutica N.V.
Status:
PATENT GRANTED

Please Sign in to use this feature